Clinical Trial: Stem Cell Therapy in Autism Spectrum Disorders
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Open Label Study of Autologous Bone Marrow Mononuclear Cells in Autism Spectrum Disorders
Brief Summary: The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with autism spectrum disorders
Detailed Summary:
Sponsor: Neurogen Brain and Spine Institute
Current Primary Outcome: Improvement in the scales for Autism spectrum disorders [ Time Frame: Six months ]
Original Primary Outcome: Same as current
Current Secondary Outcome: Positron Emission Tomography- computed tomography to study change in brain metabolism [ Time Frame: six months ]
Original Secondary Outcome: Same as current
Information By: Neurogen Brain and Spine Institute
Dates:
Date Received: October 28, 2013
Date Started: August 2009
Date Completion:
Last Updated: September 23, 2016
Last Verified: September 2016